YOCON Biology was formerly established in a warehouse in Haidian District, Beijing, with 2 members and an area of 35 m2.

After recognizing the importance and standardization of national virus sampling, YOCON independently developed virus sampling kits to formally move to the field of molecular diagnosis.

The company established a serum-free cell culture medium R&D center in Beijing.

The company completed the successful R&D of the country's leading serum-free medium, which is widely accepted, making the company become a leader in R&D of serum-free cell media in China.

After successful R&D of serum-free media for NK cells and mesenchymal stem cells, the company began the R&D of automatic cell culture workstation to establish its R&D direction.

The company has completed the successful R&D of serum-free media for hybridoma cells, CHO cells, HEK293 and other engineered cells, which are available to CDCs, scientific research institutions in universities, industrial enterprises and clinical hospitals.

After the global outbreak of COVID-19, YOCON virus sampling products, as rare products registered under Class II medical devices in China, were well accepted both at home and abroad. The company has become one of the key government-appointed enterprises for epidemic prevention and control. The company has donated virus sampling products valuing more than RMB 20.00 million, thus making great contributions to domestic and international virus detection.

Successful R&D of automatic sample processing and nucleic acid extraction workstation indicates the transformation of YOCON achievements.